Katharina Lückerath

2.6k total citations
51 papers, 1.7k citations indexed

About

Katharina Lückerath is a scholar working on Oncology, Radiology, Nuclear Medicine and Imaging and Molecular Biology. According to data from OpenAlex, Katharina Lückerath has authored 51 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Oncology, 16 papers in Radiology, Nuclear Medicine and Imaging and 14 papers in Molecular Biology. Recurrent topics in Katharina Lückerath's work include Peptidase Inhibition and Analysis (15 papers), Radiopharmaceutical Chemistry and Applications (13 papers) and Multiple Myeloma Research and Treatments (13 papers). Katharina Lückerath is often cited by papers focused on Peptidase Inhibition and Analysis (15 papers), Radiopharmaceutical Chemistry and Applications (13 papers) and Multiple Myeloma Research and Treatments (13 papers). Katharina Lückerath collaborates with scholars based in Germany, United States and Sweden. Katharina Lückerath's co-authors include Ken Herrmann, Constantin Lapa, Andreas K. Buck, Samuel Samnick, Stefan Knop, Andreas Schirbel, Saskia Kropf, Martin Schreder, Hans‐Jürgen Wester and Heribert Hänscheid and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Blood and PLoS ONE.

In The Last Decade

Katharina Lückerath

47 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Katharina Lückerath Germany	23	922	523	459	403	402	51	1.7k
Saskia Kropf Germany	20	886 1.0×	707 1.4×	235 0.5×	505 1.3×	252 0.6×	31	1.7k
Rosa Fonti Italy	23	560 0.6×	387 0.7×	489 1.1×	276 0.7×	354 0.9×	65	1.6k
Hans‐Juergen Wester Germany	22	716 0.8×	1.1k 2.0×	244 0.5×	864 2.1×	161 0.4×	38	2.0k
Tobias Dechow Germany	24	793 0.9×	463 0.9×	692 1.5×	475 1.2×	275 0.7×	73	2.0k
Dan S. Gombos United States	22	624 0.7×	313 0.6×	457 1.0×	414 1.0×	79 0.2×	87	1.9k
Matthias Holdhoff United States	27	604 0.7×	345 0.7×	596 1.3×	348 0.9×	123 0.3×	111	2.1k
Patricia LoRusso United States	21	1.1k 1.2×	405 0.8×	896 2.0×	353 0.9×	192 0.5×	66	2.0k
Tiffany K. Ricks United States	15	781 0.8×	450 0.9×	542 1.2×	206 0.5×	241 0.6×	21	1.8k
Peter Ho United States	23	780 0.8×	194 0.4×	1.1k 2.4×	354 0.9×	154 0.4×	48	2.0k
Michelle Morrow United Kingdom	14	1.3k 1.5×	212 0.4×	434 0.9×	466 1.2×	209 0.5×	34	2.0k

Countries citing papers authored by Katharina Lückerath

Since Specialization

Citations

This map shows the geographic impact of Katharina Lückerath's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Katharina Lückerath with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Katharina Lückerath more than expected).

Fields of papers citing papers by Katharina Lückerath

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Katharina Lückerath. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Katharina Lückerath. The network helps show where Katharina Lückerath may publish in the future.

Co-authorship network of co-authors of Katharina Lückerath

This figure shows the co-authorship network connecting the top 25 collaborators of Katharina Lückerath. A scholar is included among the top collaborators of Katharina Lückerath based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Katharina Lückerath. Katharina Lückerath is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Cerezo-Magaña, Myriam, Julie E. Park, Katharina Lückerath, et al.. (2025). Optimizing peptide nucleic acid-based pretargeting for enhanced targeted radionuclide therapy. Journal of Controlled Release. 381. 113551–113551.

Darr, Christopher, Elai Davicioni, Kuangyu Shi, et al.. (2025). Transcriptomic Profiling of the Tumor Immune Microenvironment Reveals Prognostic Markers in mCRPC Patients Treated with LuPSMA Therapy. Theranostics. 15(18). 9447–9458.

Ulmert, David, Julie E. Park, Katharina Lückerath, et al.. (2024). Impact of site-specific conjugation strategies on the pharmacokinetics of antibody conjugated radiotherapeutics. European Journal of Medicinal Chemistry. 280. 116927–116927.

Lückerath, Katharina, Jens T. Siveke, Benedikt M. Schaarschmidt, et al.. (2023). Novel Ga-68-FAPI PET/CT offers oncologic staging without COVID-19 vaccine-related pitfalls. Nuklearmedizin - NuclearMedicine. 62(2). 129–129. 2 indexed citations

Bicak, Mesude, Darren R. Veach, Katharina Lückerath, et al.. (2023). Quantitative In Vivo Imaging of the Androgen Receptor Axis Reveals Degree of Prostate Cancer Radiotherapy Response. Molecular Cancer Research. 21(4). 307–315. 2 indexed citations

Lückerath, Katharina, Rudolf A. Werner, Andreas Schirbel, et al.. (2022). CXCR4 expression of multiple myeloma as a dynamic process: influence of therapeutic agents. Leukemia & lymphoma. 63(10). 2393–2402. 2 indexed citations

Bicak, Mesude, Katharina Lückerath, Teja Kalidindi, et al.. (2020). Genetic signature of prostate cancer mouse models resistant to optimized hK2 targeted α-particle therapy. Proceedings of the National Academy of Sciences. 117(26). 15172–15181. 18 indexed citations

Czernin, Johannes, et al.. (2020). Immune-Checkpoint Blockade Enhances²²⁵Ac-PSMA617 Efficacy in a Mouse Model of Prostate Cancer. Journal of Nuclear Medicine. 62(2). 228–231. 70 indexed citations

Lückerath, Katharina, Andreea D. Stuparu, Wei Liu, et al.. (2018). Detection Threshold and Reproducibility of ⁶⁸Ga-PSMA11 PET/CT in a Mouse Model of Prostate Cancer. Journal of Nuclear Medicine. 59(9). 1392–1397. 21 indexed citations

10.

Lapa, Constantin, María José García‐Velloso, Katharina Lückerath, et al.. (2017). ¹¹C-Methionine-PET in Multiple Myeloma: A Combined Study from Two Different Institutions. Theranostics. 7(11). 2956–2964. 53 indexed citations

11.

Buck, Andreas K., Heribert Hänscheid, Andreas Schirbel, et al.. (2017). Chemokine receptor – Directed imaging and therapy. Methods. 130. 63–71. 43 indexed citations

12.

Lapa, Constantin, Andreas Schirbel, Samuel Samnick, et al.. (2017). The gross picture: intraindividual tumour heterogeneity in a patient with nonsecretory multiple myeloma. European Journal of Nuclear Medicine and Molecular Imaging. 44(6). 1097–1098. 8 indexed citations

13.

Lapa, Constantin, Katharina Lückerath, Camelia Maria Monoranu, et al.. (2016). ⁶⁸Ga-Pentixafor-PET/CT for Imaging of Chemokine Receptor 4 Expression in Glioblastoma. Theranostics. 6(3). 428–434. 88 indexed citations

14.

Lapa, Constantin, Martin Schreder, Andreas Schirbel, et al.. (2016). [⁶⁸Ga]Pentixafor-PET/CT for imaging of chemokine receptor CXCR4 expression in multiple myeloma - Comparison to [¹⁸F]FDG and laboratory values. Theranostics. 7(1). 205–212. 132 indexed citations

15.

Werner, Rudolf A., Katharina Lückerath, Takahiro Higuchi, et al.. (2015). Prognostic Value of Serum Tumor Markers in Medullary Thyroid Cancer Patients Undergoing Vandetanib Treatment. Medicine. 94(45). e2016–e2016. 15 indexed citations

16.

Lückerath, Katharina, Constantin Lapa, Ken Herrmann, et al.. (2015). 11C-Methionine-PET: A novel and sensitive tool for monitoring of early response to treatment in multiple myeloma. Oncotarget. 6(10). 8418–8429. 32 indexed citations

17.

Herrmann, Ken, Margret Schottelius, Constantin Lapa, et al.. (2015). First-in-Human Experience of CXCR4-Directed Endoradiotherapy with ¹⁷⁷Lu- and ⁹⁰Y-Labeled Pentixather in Advanced-Stage Multiple Myeloma with Extensive Intra- and Extramedullary Disease. Journal of Nuclear Medicine. 57(2). 248–251. 188 indexed citations

18.

Lapa, Constantin, Stefan Knop, & Katharina Lückerath. (2014). FDG PET/CT Depicts Cutaneous Plasmocytoma. Clinical Nuclear Medicine. 39(10). 910–911. 3 indexed citations

19.

Lückerath, Katharina, Constantin Lapa, Gerhard Jörg, et al.. (2013). Targeting Paraprotein Biosynthesis for Non-Invasive Characterization of Myeloma Biology. PLoS ONE. 8(12). e84840–e84840. 24 indexed citations

20.

Guardiola-Serrano, Francisca, Aurélie Rossin, Nathalie Cahuzac, et al.. (2010). Palmitoylation of human FasL modulates its cell death-inducing function. Cell Death and Disease. 1(10). e88–e88. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact